A multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site.

Kazuo Nishikawa Shuichi HironakaTakashi InagakiAzusa KomoriSatoshi OtsuKenji MitsugiAkitaka MakiyamaKoichiro WatanabeShingo TamuraYuta OkumuraHitoshi KusabaTaito EsakiEishi BabaKuniaki Shirao

Published in: Japanese journal of clinical oncology (2022)

Overall survival in site-specific and empiric treatment groups was similar in the unfavourable cancer of unknown primary site subset in this study. Further research is needed to prolong overall survival in patients in the unfavourable cancer of unknown primary site subset.

Keyphrases

papillary thyroid
squamous cell
end stage renal disease
newly diagnosed
randomized controlled trial
squamous cell carcinoma
prognostic factors
young adults
lymph node metastasis
urinary tract infection
patient reported